The soy isoflavone daidzein improves the capacity of tamoxifen to prevent mammary tumours
- 31 March 2005
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 41 (4) , 647-654
- https://doi.org/10.1016/j.ejca.2004.12.005
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Equol Is a Novel Anti-Androgen that Inhibits Prostate Growth and Hormone Feedback1Biology of Reproduction, 2004
- Chemopreventive Effects of Soy Protein and Purified Soy Isoflavones on DMBA-Induced Mammary Tumors in Female Sprague-Dawley RatsNutrition and Cancer, 2001
- Infantile leukemia and soybeans – a hypothesisLeukemia, 1999
- Genistein-Mediated Attenuation of Tamoxifen-Induced Antagonism from Estrogen Receptor-Regulated GenesBiochemical and Biophysical Research Communications, 1998
- Antioxidant Efficacy of Phytoestrogens in Chemical and Biological Model SystemsArchives of Biochemistry and Biophysics, 1998
- Interaction of Estrogenic Chemicals and Phytoestrogens with Estrogen ReceptorEndocrinology, 1998
- Chemoprevention of N‐Nitroso‐N‐methylurea‐induced Rat Mammary Cancer by Miso and Tamoxifen, Alone and in CombinationJapanese Journal of Cancer Research, 1998
- Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cellsin vitroNutrition and Cancer, 1997
- Inhibition of DNA topoisomerases I and II and induction of apoptosis by erbstatin and tyrphostin derivativesBiochemical Pharmacology, 1994
- Soy intake and cancer risk: A review of thein vitroandin vivodataNutrition and Cancer, 1994